Generic Name and Formulations:
Meclizine HCl 12.5mg, 25mg; tabs.
Various generic manufacturers
Indications for Meclizine:
Motion sickness prophylaxis. Vertigo of vestibular origin.
Motion sickness: 25–50mg 1 hour prior to departure, repeated every 24 hours as needed. Vertigo: 25–100mg/day in divided doses.
Asthma. Glaucoma. GI or GU obstruction. Hepatic or renal impairment. Elderly. Pregnancy (Cat.B). Nursing mothers.
Alcohol, tranquilizers, sedative-hypnotics potentiate CNS depression. May be potentiated by CYP2D6 inhibitors.
Drowsiness, sedation, dry mouth, blurred vision.
Formerly known under the brand name Antivert.
Neurology Advisor Articles
- Erenumab Superior to Placebo for Reducing Migraine Disability, Improving HRQoL
- Congress Passes Bill to Fight Opioid Crisis
- Managing Status Epilepticus in Palliative Care: Accounting for Patient and Family Experience
- Physical Activity Decreases Vascular Comorbidities in Multiple Sclerosis
- Review of Factors Impacting Sport-Related Concussion Headaches
- Anodal tDCS Offers Possible Benefit for Improving Item Recall in Post-Stroke Aphasia
- Hospitalization Tied to Brain Abnormalities in Older Adults
- Spending Often Persists in High-Cost Medicare-Medicaid Eligible
- Skills-Based Intervention Did Not Cut Systolic BP After Stroke, TIA
- High Frequency of Headaches Following Dialysis Associated With BUN and Blood Pressure